Comparison of CT‐based volumetric dosimetry with traditional prescription points in the treatment of cervical cancer with PDR brachytherapy. Issue 5 (29th July 2015)

• Record Type: Journal Article
• Authors: Lowrey, Nicola; Nilsson, Sanna; Moutrie, Zoe; Chan, Philip; Cheuk, Robyn
• Is Part Of: Journal of medical imaging and radiation oncology. Volume 59:Issue 5(2015:Oct.)
• Page Start: 640
• Page End: 645
• Publication Date: 2015-07-29
• Subjects: Radiology, Medical -- Periodicals; Radiology, Medical -- Australasia -- Periodicals; 616.0757
• DOI: 10.1111/1754-9485.12341
• Languages: English
• ISSNs: 1754-9477

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <sec id="jmiro12341-sec-0001" sec-type="section"> <title>Introduction</title> <p>The traditional use of two‐dimensional geometric prescription points in intracavitary brachytherapy planning for locally advanced cervical cancer is increasingly being replaced by three‐dimensional (3D) planning. This study aimed to directly compare the two planning methods to validate that CT planning provides superior dosimetry for both tumour and organs at risk (OARs) in our department.</p> </sec> <sec id="jmiro12341-sec-0002" sec-type="section"> <title>Methods</title> <p>The CT planning data of 10 patients with locally advanced cervical cancer was audited. For each CT dataset, two new brachytherapy plans were created, comparing the dosimetry of conventional American Brachytherapy Society points and 3D‐optimised volumes created for the high‐risk clinical target volume (HR CTV) and OARs. Total biologically equivalent doses for these structures were calculated using the modified EQD2 formula and comparative dose‐volume histogram (DVH) analysis performed.</p> </sec> <sec id="jmiro12341-sec-0003" sec-type="section"> <title>Results</title> <p>DVH analysis revealed that for the 3D‐optimised plans, the prescription aim of D90 ≥ 100% was achieved for the HR CTV in all 10 patients. However, when prescribing to point A, only 50% of the plans achieved the minimum required dose to the HR CTV. Rectal and bladder dose constraints were met for all 3D‐optimised plans but exceeded in two and one of the conventional plans, respectively.</p> </sec> <sec id="jmiro12341-sec-0004" sec-type="section"> <title>Conclusions</title> <p>This study confirms that the regionally relevant practice of CT‐based 3D‐optimised planning results in improved tumour dose coverage compared with traditional points‐based planning methods and also improves dose to the rectum and bladder.</p> </sec> </abstract>